Results 241 to 250 of about 2,896,241 (272)
Sustained blood pressure reduction associated with percutaneous auricular vagus nerve stimulation in hypertensive chronic pain patients: a retrospective dual-center analysis. [PDF]
Berger L +8 more
europepmc +1 more source
Updates in the 2025 AHA/ACC Hypertension Guideline. [PDF]
Brown C, Clark D, Jones DW.
europepmc +1 more source
Current perspectives and challenges of digital hypertension: artificial intelligence in the management of hypertension. [PDF]
Yin Z, Miao H, Zhou Z, Li X, Zhang Y.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Blood pressure (BP) assessment—from BP level to BP variability
Pediatric Nephrology, 2015The assessment of blood pressure (BP) can be challenging in children, especially in very young individuals, due to their variable body size and lack of cooperation. In the absence of data relating BP with cardiovascular outcomes in children, there is a need to convert absolute BP values (in mmHg) into age-, gender- and height appropriate BP percentiles
Janusz, Feber, Mieczyslaw, Litwin
openaire +2 more sources
1971
The aim of this note is to provide detailed information about the Brown-Peterson spectrum BP as obtained from MUQ 2 by the Quillen splitting C8S . In particular, we present convenient polynomial generators for rC.(Bp) and give the fundamental parameters of the structure of BP-homology as explicit expressions in terms of our generators.
openaire +1 more source
The aim of this note is to provide detailed information about the Brown-Peterson spectrum BP as obtained from MUQ 2 by the Quillen splitting C8S . In particular, we present convenient polynomial generators for rC.(Bp) and give the fundamental parameters of the structure of BP-homology as explicit expressions in terms of our generators.
openaire +1 more source
Current opinion in investigational drugs (London, England : 2000), 2000
BP-897 is a dopamine D3 receptor agonist which is under development by Bioprojet for the potential treatment of drug craving and vulnerability to relapse that are elicited by drug-associated environmental stimuli; it is undergoing phase I trials [318397,334036,340721].
openaire +4 more sources
BP-897 is a dopamine D3 receptor agonist which is under development by Bioprojet for the potential treatment of drug craving and vulnerability to relapse that are elicited by drug-associated environmental stimuli; it is undergoing phase I trials [318397,334036,340721].
openaire +4 more sources

